Vor Biopharma Inc (VOR) Stock Price

24.735 ▼ -0.765 (-3.00%)
Open: 25.00 Vol: 0 Day's range: 24.65 - 25.56 Oct 30, 15:17 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VOR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 24.79▲ 24.79▲ 24.87▲ 26.53▼ 29.95▼
MA10 24.77▲ 24.92▼ 24.98▼ 27.31▼ 21.63▲
MA20 24.89▼ 25.05▼ 25.73▼ 29.94▼ 11.75▲
MA50 25.06▼ 26.35▼ 26.73▼ 19.80▲ 5.22▲
MA100 25.21▼ 26.86▼ 28.40▼ 10.73▲ 3.35▲
MA200 26.46▼ 28.72▼ 32.10▼ 5.77▲ 4.12▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.010▲ 0.061▲ -0.018▼ -1.465▼ 2.101▲
RSI 48.358▼ 39.041▼ 36.422▼ 45.324▼ 67.956▲
STOCH 42.484     22.783     30.222     26.136     64.181    
WILL %R -52.703     -74.176     -54.096     -82.864▼ -51.691    
CCI 42.517     -38.040     -66.504     -125.741▼ 45.445    
Latest Filters Detected On VOR
CDL $VOR Doji Star Candlestick Pattern Detected Set Alert
CDL $VOR Doji Candlestick Pattern Detected Set Alert
Vor Biopharma Inc News
Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data
Wednesday, October 29, 2025 08:13 AM
Telitacicept delivered consistent quality-of-life improvement across both treatment and placebo crossover arms 100% of patients on telitacicept for 48 weeks achieved ≥2-point Myasthenia Gravis ...
Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjögren’s Disease
Wednesday, October 22, 2025 01:42 PM
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it will host a live webcast to present and discuss the newly ...
Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 IgA Nephropathy Clinical Study at American Society of Nephrology’s Kidney Week 2025
Friday, October 17, 2025 05:19 AM
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from Stage A of a Phase 3 study in China sponsored ...
VOR historical stock data
date open high low close volume
30/10/25 25.00 25.56 24.65 24.885 148,928
29/10/25 26.79 26.80 23.12 25.50 954,000
28/10/25 27.89 28.66 26.80 26.925 372,200
27/10/25 27.20 28.467 26.00 28.13 366,100
24/10/25 27.36 28.215 27.05 27.19 276,900
23/10/25 25.76 28.31 25.60 27.76 292,600
22/10/25 27.00 27.45 25.99 26.50 289,423
21/10/25 30.075 30.38 27.41 27.77 348,800
20/10/25 29.95 30.40 29.00 29.43 331,600
17/10/25 28.66 31.31 28.65 29.00 613,700
Quote Details
52wk Low:0.132
52wk High:49.95
Vol:0
Avg Vol(3m):58.4M
1Y Chng:+2,674.25%
1M Chng:-8.81%
Add to Watch List
More Information
Index US Composite
Market Cap. 184.54M